Most of the world’s population in less developed and developing countries have been infected with EBV human herpesvirus 4 by age one and show no ill effects, even where medical care is poor. In contrast, individuals in industrialized countries are ordinarily infected after puberty, and these older patients tend to have more severe reactions to infection despite better overall health and access to medical care. Explain this apparent paradox.

검증된 단계별 안내

Step 1: Understand the nature of Epstein-Barr Virus (EBV) infection and its epidemiology. EBV is a human herpesvirus that infects most people worldwide, often during childhood in less developed countries and later in life in industrialized countries.

Step 2: Recognize that early infection (usually in infancy) in less developed countries often leads to asymptomatic or mild infections because the immune system of infants responds differently, and maternal antibodies may provide some protection.

Step 3: Note that in industrialized countries, delayed infection until adolescence or adulthood means the immune system encounters EBV for the first time at a more mature stage, which can trigger a stronger immune response.

Step 4: Understand that this stronger immune response in older individuals can cause more severe symptoms, such as infectious mononucleosis, due to the body's vigorous reaction to the virus.

Step 5: Conclude that the paradox arises because early exposure leads to immune tolerance or mild infection, while delayed exposure results in a more intense immune reaction, explaining why poorer medical care does not necessarily correlate with more severe disease in this context.

비슷한 문제에 대한 검증된 영상 답변:

이 영상 해법은 위 문제에 도움이 된다고 튜터들이 추천한 것입니다.

영상 길이:

도움이 되었나요?

주요 개념

질문에 올바르게 답하기 위해 반드시 이해해야 하는 핵심 개념들은 다음과 같습니다.

Epstein-Barr Virus (EBV) Infection and Transmission

EBV is a common human herpesvirus transmitted primarily through saliva. Infection usually occurs early in life in developing countries, often asymptomatically, while in industrialized countries, infection tends to occur later, typically during adolescence or adulthood, leading to different clinical outcomes.

Immune System Maturation and Response

The immune system's maturity affects how the body responds to EBV. Infants have an immature immune system that often tolerates the virus with minimal symptoms, whereas older individuals have a more developed immune response that can cause stronger symptoms, such as infectious mononucleosis.

Epidemiological and Socioeconomic Factors

Differences in living conditions, hygiene, and social interactions influence the age of EBV infection. In less developed regions, early exposure is common due to close contact and lower hygiene standards, while in industrialized countries, delayed exposure results from better sanitation and social behaviors, impacting disease severity.